Articles Vol. 64 No. 6 21/10/2023

16. CARDIOVASCULAR RISK STRATIFICATION AND CARDIOVASCULAR DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AT OUTPATIENT CLINICS, NHAN DAN GIA DINH HOSPITAL

Nguyen Thi Thu Thuy1,2, Dinh Quoc Bao1,2, Nguyen Van Si1,2
1 University of Medicine and Pharmacy at HCMC
2 Đại học Y Dược thành phố Hồ Chí Minh
Corresponding author: si.nguyen@ump.edu.vn
DOI: 10.52163/yhc.v64i6.820
19 Views
7 Downloads
Keywords
Type 2 diabetes mellitus, cardiovascular risk, cardiovascular disease.
Abstract

Background: Type 2 diabetes mellitus (T2DM) is a popular condition and cardiovascular risk factor in Vietnam. Thanks to advanced diagnostic and treatment methods, individuals with T2DM have an extended life expectancy. However, this comes with increased diabetes-related complications, including cardiovascular diseases. Understanding cardiovascular risk and cardiovascular disease characteristics is essential in effectively caring for individuals with T2DM.

Aims: The study was conducted to estimate the global cardiovascular risk and cardiovascular disease in T2DM patients at outpatient clinics.

Method: A descriptive cross-sectional study was conducted at the endocrinology clinic and cardiology clinic of Nhan Dan Gia Dinh Hospital from March 2021 to March 2022. The hospital’s Ethics Committee approved the study with protocol number 37/NDGĐ-HĐĐĐ dated 30/3/2022

Results: A total of 515 patients participated in the study, with an average age of 66, higher in the cardiology clinic than the endocrinology clinic. Female gender dominance was observed in both clinics. Cardiovascular risk ranged from high to very high and differed between the two clinics, with high risk being predominant in the endocrinology clinic and very high risk being predominant in the cardiology clinic. Cardiovascular diseases included Coronary artery disease at 47.8%, stroke at 2.5%, heart failure at 4.9%, and peripheral artery disease at 0.6%.

Conclusion: T2DM patients receiving outpatient treatment at Nhan Dan Gia Dinh Hospital have a cardiovascular risk ranging from high to very high, with a notable prevalence of cardiovascular disease, even in the endocrinology clinic. Therefore, comprehensive control of cardiovascular risk factors and appropriate selection of blood glucose-lowering treatments for this high-risk group are crucial.

References
[1]
The World Bank, Diabetes prevalence (% of Google Scholar
[2]
population ages 20 to 79) – Vietnam. https:// Google Scholar
[3]
data.worldbank.org/indicator/SH.STA.DIAB. Google Scholar
[4]
ZS?locations=VN Google Scholar
[5]
Ke C, Lipscombe LL, Weisman A et al., Google Scholar
[6]
Trends in the Association Between Diabetes Google Scholar
[7]
and Cardiovascular Events, 1994-2019. JAMA. Google Scholar
[8]
Nov 8;328(18):1866-1869. doi: 10.1001/ Google Scholar
[9]
jama.2022.14914. PMID: 36239969; PMCID: Google Scholar
[10]
PMC9568883. Google Scholar
[11]
Balakumar P, Maung-U K, Jagadeesh G, Google Scholar
[12]
Prevalence and prevention of cardiovascular Google Scholar
[13]
disease and diabetes mellitus. Pharmacol Res. Google Scholar
[14]
Nov;113(Pt A):600-609. doi: 10.1016/j. Google Scholar
[15]
phrs.2016.09.040. Epub 2016 Sep 30. PMID: Google Scholar
[16]
Shaughnessy AF, ADA/EASD Updated Google Scholar
[17]
Guidelines: Glycemic Control Is Only Part of Google Scholar
[18]
the Management of Type 2 Diabetes. Am Fam Google Scholar
[19]
Physician. 2023 May;107(5):Online. PMID: Google Scholar
[20]
Davies MJ, Aroda VR, Collins BS et al., Google Scholar
[21]
Management of Hyperglycemia in Type 2 Google Scholar
[22]
Diabetes, 2022. A Consensus Report by the Google Scholar
[23]
American Diabetes Association (ADA) and Google Scholar
[24]
the European Association for the Study of Google Scholar
[25]
Diabetes (EASD). Diabetes Care. 2022 Nov Google Scholar
[26]
;45(11):2753-2786. doi: 10.2337/dci22-0034. Google Scholar
[27]
PMID: 36148880; PMCID: PMC10008140. Google Scholar
[28]
Regassa LD, Tola A, Ayele Y, Prevalence of Google Scholar
[29]
Cardiovascular Disease and Associated Factors Google Scholar
[30]
Among Type 2 Diabetes Patients in Selected Google Scholar
[31]
Hospitals of Harari Region, Eastern Ethiopia. Google Scholar
[32]
Front Public Health. 2021 Feb 5;8:532719. doi: Google Scholar
[33]
3389/fpubh.2020.532719. PMID: 33614562; Google Scholar
[34]
PMCID: PMC7892600. Google Scholar
[35]
Bộ Y tế, Hướng dẫn chẩn đoán và điều trị đái Google Scholar
[36]
tháo đường típ 2 (Ban hành kèm theo Quyết định Google Scholar
[37]
số 5481/QĐ-BYT ngày 30 tháng 12 năm 2020). Google Scholar
[38]
https://daithaoduong.kcb.vn/huong-dan-chan Google Scholar
[39]
doan-va-dieu-tri-dai-thao-duong-tip-2 Google Scholar
[40]
Cosentino F, Grant PJ, Aboyans V et al., ESC Google Scholar
[41]
Scientific Document Group. 2019 ESC Guidelines Google Scholar
[42]
on diabetes, pre-diabetes, and cardiovascular130 Google Scholar
[43]
diseases developed in collaboration with the Google Scholar
[44]
EASD. Eur Heart J. 2020 Jan 7;41(2):255-323. Google Scholar
[45]
doi: 10.1093/eurheartj/ehz486. Erratum in: Google Scholar
[46]
Eur Heart J. 2020 Dec 1;41(45):4317. PMID: Google Scholar
[47]
Nguyễn Văn Tuấn, Phan Thị Hà Linh, Rối loạn Google Scholar
[48]
lipid máu và nguy cơ tim mạch ở bệnh nhân đái Google Scholar
[49]
tháo đường type 2; Tạp chí Y học Việt Nam, Google Scholar
[50]
(1), 2022, https://doi.org/10.51298/vmj. Google Scholar
[51]
v513i1.2353 Google Scholar
[52]
Soetedjo NNM, McAllister SM, UgarteGil C et al., Google Scholar
[53]
TANDEM Consortium. Disease Google Scholar
[54]
characteristics and treatment of patients Google Scholar
[55]
with diabetes mellitus attending government Google Scholar
[56]
health services in Indonesia, Peru, Romania Google Scholar
[57]
and South Africa. Trop Med Int Health. 2018 Google Scholar
[58]
Oct;23(10):1118-1128. doi: 10.1111/tmi.13137. Google Scholar
[59]
Epub 2018 Sep 10. PMID: 30106222. Google Scholar
[60]
Kalra S, Sharma SK, Diabetes in the Elderly. Google Scholar
[61]
Diabetes Ther. 2018 Apr;9(2):493-500. doi: Google Scholar
[62]
1007/s13300-018-0380-x. Epub 2018 Feb 19. Google Scholar
[63]
PMID: 29460258; PMCID: PMC6104259. Google Scholar
[64]
Kubota Y, Shimizu W, Clinical Benefits of Google Scholar
[65]
Sodium-Glucose Cotransporter 2 Inhibitors and Google Scholar
[66]
the Mechanisms Underlying Their Cardiovascular Google Scholar
[67]
Effects. JACC Asia; 2022 Jun 7;2(3):287- Google Scholar
[68]
doi: 10.1016/j.jacasi.2022.03.009. PMID: Google Scholar
[69]
; PMCID: PMC9627935. Google Scholar
[70]
Ussher JR, Drucker DJ, Glucagon-like peptide Google Scholar
[71]
receptor agonists: cardiovascular benefits and Google Scholar
[72]
mechanisms of action. Nat Rev Cardiol. 2023 Google Scholar
[73]
Jul;20(7):463-474. doi: 10.1038/s41569-023- Google Scholar
[74]
-3, Epub 2023 Mar 28. PMID: 36977782. Google Scholar